22 May 2013
Keywords: taxol, competitor, ivax, nears, market, napro, biotherapeutics
Article | 25 September 1997
NaPro BioTherapeutics and partner IVAX Corp have been successful ingaining a positive recommendation for approval for their version of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.